zithromax and Prostatic-Hyperplasia

zithromax has been researched along with Prostatic-Hyperplasia* in 1 studies

Other Studies

1 other study(ies) available for zithromax and Prostatic-Hyperplasia

ArticleYear
Concentration of azithromycin in human prostatic tissue.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:10

    Prostatic tissue was obtained from 36 patients at two study locations and assayed for azithromycin by HPLC or bioassay. The mean concentration of azithromycin in human prostatic tissue (2.54 micrograms/ml) 14 h after 500 mg oral dosing (two 250 mg doses 12 h apart) was much greater than plasma concentrations (less than or equal to 0.1 micrograms/ml). Azithromycin was slowly eliminated from prostatic tissue (half-life 60 h) and a mean concentration of 0.62 micrograms/ml remained 137 h after dosing.

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azithromycin; Chromatography, High Pressure Liquid; Erythromycin; Half-Life; Humans; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Time Factors

1991